Pason, Laurincio M.

HRN: 29-33-99  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2026
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/22/2026
07/28/2026
IV
500MG
Q8
MULTUPLE LACERATED WOUNDS
Pending Pharmacy Acceptance 

 Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: